PROM1 and cancer: The present study demonstrates for the first time the contribution made by CD133 to tumor formation and progression in a model where multiple phenotypic cancer cell subpopulations coexist in dynamic equilibrium and where the tumorigenic and metastatic properties of subsets of cells, including CSCs, can be tested concurrently to identify their functional and hierarchical relationships.